Rockwell Medical (RMTI) Tops Q1 EPS by 3c, provides guidance
Rockwell Medical (NASDAQ: RMTI) reported Q1 EPS of ($0.01), $0.03 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $18.9 million versus the consensus estimate of $19.14 million.
GUIDANCE:
Rockwell Medical sees FY2025 revenue of $65-70 million, versus the consensus of $67.424 million.
For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.
